ATF5 and malignant glioma: ATF5 then activates the transcription of the anti-apoptotic gene myeloid cell leukemia sequence 1 (MCL1) transcription by binding its promoter and increasing the malignant glioma survival through the CREB3L2/ATF5/MCL1 anti-apoptotic pathway.